BMRN vs MEDP
BioMarin Pharmaceutical vs Medpace — AI-powered side-by-side comparison
| Metric | BMRN | MEDP |
|---|---|---|
| AI Score | 48 | 51 |
| Price | $59.60 | — |
| P/E Ratio | 42.56× | 33.11× |
| ROE | 0.1% | 1.0% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 0.3% |
| Debt / Equity | 0.23× | 0.20× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 59.1 | 57.7 |
| Beta | 0.239 | 1.151 |
| Expected Upside | +6.9% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMRN Full Analysis
MEDP Full Analysis